Search This Blog

Tuesday, November 1, 2016

Bank of America Merrill Lynch Seventh Returning Talent Programme Opens for Applications | Bank of America Newsroom

Today, Bank of America Merrill Lynch opens applications for its seventh UK Returning Talent programme. Individuals who have been out of work for 12 months or longer (former stay-at-home parents or carers, or someone who has chosen to take a career break, for example), are invited to apply via the company's Careers site. The application closing date is 6 December.



Bank of America Merrill Lynch Seventh Returning Talent Programme Opens for Applications | Bank of America Newsroom

Getting Business Funding Can be Daunting, but There's Hope

Vendedy is the first social network designed to connect global travelers to street markets. Founded by Forbes30Under30 Entrepreneur Christine Souffrant Ntim, the small business’s goal is to digitize the $10 trillion dollar street market economy and make it accessible to anyone and everyone.



Getting Business Funding Can be Daunting, but There's Hope

Feds Short-changed Small Businesses Out of $200 Billion in Contracts in 2015 Alone, Says Advocacy Group

The United States government agency responsible for supporting entrepreneurs has been accused of short-changing small business owners out of $2 trillion in federal contracts over the last ten years.
Federal law currently dictates that small businesses must receive a minimum of 23 percent of all government contracts granted, and the Small Business Administration (SBA) is responsible for helping to ensure that target is met by connecting government agencies with business owners.


Feds Short-changed Small Businesses Out of $200 Billion in Contracts in 2015 Alone, Says Advocacy Group

Meet the man who spent $9 million on a license plate - Oct. 31, 2016

For high-rolling drivers in the United Arab Emirates, no car is complete without a single-digit license plate.



The oil-rich country's wealthy elite are willing to drop millions of dollars to get their hands on one.



Meet the man who spent $9 million on a license plate - Oct. 31, 2016

New Bristol-Myers Squibb Research on Opdivo (nivolumab) Monotherapy and in Combination With Yervoy (ipilimumab) at SMR 2016 Congress Reinforces Immuno-Oncology Leadership and Scientific Expertise in Melanoma | BMS Newsroom

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today announced new data presentations from studies evaluating Opdivo (nivolumab) as monotherapy or in combination with Yervoy (ipilimumab) in the treatment of melanoma, including new research on the efficacy and safety of the combination in melanoma patients with high unmet need including those with elevated serum lactate dehydrogenase (LDH) and brain metastases. Additional presentations will also highlight new data on health economics and real-world outcomes in patients living with the disease.



New Bristol-Myers Squibb Research on Opdivo (nivolumab) Monotherapy and in Combination With Yervoy (ipilimumab) at SMR 2016 Congress Reinforces Immuno-Oncology Leadership and Scientific Expertise in Melanoma | BMS Newsroom